Soluble PD‑L1 reflects cachexia status in patients with gastric cancer and is an independent prognostic marker for relapse‑free survival after radical surgery-Reference-Cited by-同舟云学术

Soluble PD‑L1 reflects cachexia status in patients with gastric cancer and is an independent prognostic marker for relapse‑free survival after radical surgery

Published:2023-03-20 Issue:5 Volume:18 Page:
ISSN:2049-9450
Container-title:Molecular and Clinical Oncology
language:
Short-container-title:Mol Clin Oncol

Author:

Matsumoto Yasunori¹,Sasaki Takuma¹,Kano Masayuki¹,Shiraishi Tadashi¹,Suito Hiroshi¹,Murakami Kentaro¹,Toyozumi Takeshi¹,Otsuka Ryota¹,Kinoshita Kazuya¹,Iida Shinichiro¹,Morishita Hiroki¹,Nishioka Yuri¹,Hayano Koichi¹,Kurata Yoshihiro¹,Hayashi Hideki¹,Matsubara Hisahiro¹

Affiliation:

1. Department of Frontier Surgery, Chiba University Graduate School of Medicine, Chiba 2608670, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construction and validation of the prognostic nomogram model for patients with diffuse-type gastric cancer based on the SEER database;Discover Oncology;2024-07-24

2. Soluble immune checkpoints: implications for cancer prognosis and response to immune checkpoint therapy and conventional therapies;Journal of Experimental & Clinical Cancer Research;2024-05-31

3. Regulatory T cells as crucial trigger and potential target for hyperprogressive disease subsequent to PD-1/PD-L1 blockade for cancer treatment;International Immunopharmacology;2024-05

4. Circulating factors in cancer cachexia: recent opportunities for translational research;Current Opinion in Clinical Nutrition & Metabolic Care;2024-03-26

5. Can sPD-1 and sPD-L1 Plasma Concentrations Predict Treatment Response among Patients with Extraparenchymal Neurocysticercosis?;Pathogens;2023-09-01